Concepedia

Publication | Open Access

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial

DOIFull Paper Access

22

Citations

30

References

2023

Year

Johanna Hammersen, Sebastian Birndt, Konstanze Döhner, Philipp A. Reuken, Andreas Stallmach, Paul Sauerbrey, F. La Rosée, Markus Pfirrmann, Christian Fabisch, Karl Träger,
Leukemia

References

YearCitations

Page 1